{"id":"https://openalex.org/W2989203189","doi":"https://doi.org/10.1182/blood-2019-130700","title":"HDAC8 Maintain Cytoskeleton Integrity Via Homologous Recombination and Represent a Novel Therapeutic Target in Multiple Myeloma","display_name":"HDAC8 Maintain Cytoskeleton Integrity Via Homologous Recombination and Represent a Novel Therapeutic Target in Multiple Myeloma","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2989203189","doi":"https://doi.org/10.1182/blood-2019-130700","mag":"2989203189"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-130700","doi":"https://doi.org/10.1182/blood-2019-130700","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-130700","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061988911","display_name":"Zuzana Chyra","orcid":"https://orcid.org/0000-0003-4807-2532","observed_orcids":["https://orcid.org/0000-0003-4807-2532"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I187293425","display_name":"University of Ostrava","ror":"https://ror.org/00pyqav47","country_code":"CZ","type":"education","lineage":["https://openalex.org/I187293425"]},{"id":"https://openalex.org/I4210088935","display_name":"University Hospital Ostrava","ror":"https://ror.org/00a6yph09","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210088935"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["CZ","US"],"is_corresponding":false,"raw_author_name":"Zuzana Chyra","raw_affiliation_strings":["Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston,","Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic","University Hospital Ostrava, Department of Haemato-Oncology, Ostrava, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic","institution_ids":["https://openalex.org/I187293425"]},{"raw_affiliation_string":"University Hospital Ostrava, Department of Haemato-Oncology, Ostrava, Czech Republic","institution_ids":["https://openalex.org/I4210088935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044318093","display_name":"Maria Aslani Gkotzamanidou","orcid":"https://orcid.org/0000-0003-0756-7176","observed_orcids":["https://orcid.org/0000-0003-0756-7176"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Maria Gkotzamanidou","raw_affiliation_strings":["Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston,","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082362772","display_name":"Vassilis L. Souliotis","orcid":"https://orcid.org/0000-0002-2945-1329","observed_orcids":["https://orcid.org/0000-0002-2945-1329"]},"institutions":[{"id":"https://openalex.org/I4210127711","display_name":"National Hellenic Research Foundation","ror":"https://ror.org/033m02g29","country_code":"GR","type":"funder","lineage":["https://openalex.org/I4210127711"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Vassilis L. Souliotis","raw_affiliation_strings":["Institute of Chemical Biology, National Hellenic Research Foundation, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Chemical Biology, National Hellenic Research Foundation, Athens, Greece","institution_ids":["https://openalex.org/I4210127711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100331702","display_name":"Yan Xu","orcid":"https://orcid.org/0000-0002-6167-3319","observed_orcids":["https://orcid.org/0000-0002-6167-3319"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Xu","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet K. Samur","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042880525","display_name":"Aaron B. Beeler","orcid":"https://orcid.org/0000-0002-2447-0651","observed_orcids":["https://orcid.org/0000-0002-2447-0651"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron B. Beeler","raw_affiliation_strings":["Department of Chemistry and Center for Molecular Discovery, Boston University, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and Center for Molecular Discovery, Boston University, Boston,","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090512266","display_name":"Roman H\u00e1jek","orcid":"https://orcid.org/0000-0001-6955-6267","observed_orcids":["https://orcid.org/0000-0001-6955-6267"]},"institutions":[{"id":"https://openalex.org/I187293425","display_name":"University of Ostrava","ror":"https://ror.org/00pyqav47","country_code":"CZ","type":"education","lineage":["https://openalex.org/I187293425"]},{"id":"https://openalex.org/I21449261","display_name":"Masaryk University","ror":"https://ror.org/02j46qs45","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21449261"]},{"id":"https://openalex.org/I4210088935","display_name":"University Hospital Ostrava","ror":"https://ror.org/00a6yph09","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210088935"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Roman Hajek","raw_affiliation_strings":["Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic","Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic","Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic","institution_ids":["https://openalex.org/I21449261"]},{"raw_affiliation_string":"Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic","institution_ids":["https://openalex.org/I4210088935"]},{"raw_affiliation_string":"Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic","institution_ids":["https://openalex.org/I187293425"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"4385","last_page":"4385"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5038999915122986,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5038999915122986,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.48559999465942383,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hdac8","display_name":"HDAC8","score":0.9980000257492065},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.996999979019165},{"id":"https://openalex.org/keywords/histone-deacetylase","display_name":"histone deacetylase","score":0.6669999957084656},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.921999990940094},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cytoskeleton-integrity","display_name":"cytoskeleton integrity","score":0.8320000171661377},{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.8309999704360962},{"id":"https://openalex.org/keywords/epigenetic-therapy","display_name":"epigenetic therapy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.7369999885559082},{"id":"https://openalex.org/keywords/scm3","display_name":"Scm3","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cohesin","display_name":"cohesin","score":0.8159999847412109},{"id":"https://openalex.org/keywords/myeloma-cell-proliferation","display_name":"myeloma cell proliferation","score":0.7350000143051147},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5490000247955322},{"id":"https://openalex.org/keywords/pan-hdac-inhibitors","display_name":"pan-HDAC inhibitors","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.6272637844085693},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.5720981359481812},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5671412348747253},{"id":"https://openalex.org/C25737173","wikidata":"https://www.wikidata.org/wiki/Q18042128","display_name":"HDAC8","level":5,"score":0.5666556358337402},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5294988751411438},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5178425908088684},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.49685433506965637},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4324987232685089},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4131106436252594},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.39151817560195923},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.36096036434173584},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3267802298069},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.26725852489471436},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.19898435473442078},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17295753955841064}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-130700","doi":"https://doi.org/10.1182/blood-2019-130700","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-130700","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4251850711","https://openalex.org/W2567076296","https://openalex.org/W3211787825","https://openalex.org/W3204420821","https://openalex.org/W2055588591","https://openalex.org/W2932314044","https://openalex.org/W1658998365","https://openalex.org/W2557904664","https://openalex.org/W1984518316","https://openalex.org/W7223405737"],"abstract_inverted_index":{"Multiple":[0],"Myeloma":[1],"(MM)":[2],"is":[3,44,97,124,261],"a":[4,84,115,144,185,221,282,307,333,342,368],"plasma":[5],"cell":[6,120,149,330,338,452],"malignancy":[7],"vulnerable":[8],"to":[9,58,127,160,211,253,271],"epigenetic":[10,21],"intervention,":[11],"with":[12,25,62,68,136,217,273,296,318,326,378,394],"histone":[13],"deacetylases":[14],"(HDACs)":[15],"emerging":[16],"as":[17,33,267],"the":[18,50,79,164,179,255,303,444],"most":[19],"promising":[20],"targets":[22],"in":[23,37,71,91,114,143,153,163,171,190,196,202,246,249,258,341,354,365,385,390,423,432,448,460,467,469],"combination":[24,429,468],"current":[26],"anti-myeloma":[27],"agents.":[28],"Pan-HDAC":[29],"inhibitors":[30],"are":[31,435],"effective":[32,420],"therapeutic":[34,370,463],"agents":[35],"both":[36,353],"preclinical":[38],"and":[39,52,102,131,138,151,167,193,204,214,219,291,310,344,356,381,387,431,451,454,466],"clinical":[40],"setting;":[41],"however,":[42],"there":[43,96],"an":[45,161],"increasing":[46],"emphasis":[47],"on":[48,66,426],"understanding":[49],"biological":[51],"molecular":[53,101,427],"roles":[54],"of":[55,82,86,105,112,118,134,147,188,223,229,236,238,244,286,305,321,332,336,399,414,446],"individual":[56],"HDACs":[57],"limit":[59],"toxicities":[60],"observed":[61,208,364],"pan-HDAC":[63],"inhibitors.":[64],"Based":[65,425],"correlation":[67],"patient":[69],"outcome":[70],"three":[72],"independent":[73],"myeloma":[74,148],"datasets,":[75],"we":[76,207,300],"have":[77,108,301],"evaluated":[78],"functional":[80],"role":[81,243,445],"HDAC8,":[83],"member":[85,222],"Class":[87],"I":[88],"HDAC":[89],"isoenzymes,":[90],"MM.":[92,250,424,470],"Unlike":[93],"other":[94],"isoforms,":[95],"limited":[98],"information":[99],"about":[100],"epigenomic":[103],"functions":[104],"HDAC8.":[106],"We":[107],"previously":[109],"confirmed":[110,375],"expression":[111],"HDAC8":[113,135,157,189,209,230,256,272,297,312,400,415,447],"large":[116,334],"panel":[117,335],"MM":[119,172,197,259,337,391],"lines,":[121],"where":[122],"it":[123],"localized":[125],"predominantly":[126],"cytoplasm.":[128],"Moreover,":[129,396],"genetic":[130],"pharmacological":[132,397],"modulation":[133],"RNAi":[137],"specific":[139],"inhibitor":[140,313],"PCI-34051":[141],"resulted":[142],"significant":[145,242,379],"inhibition":[146,158,320,398],"proliferation":[150],"decrease":[152,384],"colony":[154],"formation":[155],"(p<.001).":[156],"led":[159],"increase":[162],"ongoing":[165],"spontaneous":[166],"radiation-induced":[168],"DNA":[169,176,194,449],"damage":[170],"cells":[173,232,260,392],"by":[174],"affecting":[175],"repair":[177,195],"via":[178],"homologous":[180],"recombination":[181],"(HR)":[182],"pathway,":[183],"suggesting":[184],"novel":[186,308],"function":[187],"promoting":[191],"HR":[192,403],"cells.":[198],"Using":[199],"laser":[200],"micro-irradiation":[201],"MM1S":[203],"U2OS":[205],"cells,":[206],"recruitment":[210],"DSBs":[212],"sites":[213],"its":[215],"co-localization":[216],"Rad51":[218],"Scm3,":[220],"cohesin":[224],"complex.":[225],"A":[226],"transcriptomic":[227],"analysis":[228,252,374],"knock-down":[231],"also":[233],"shows":[234],"perturbation":[235],"number":[237],"cytoskeleton-related":[239],"genes":[240],"confirming":[241],"HAD8":[245],"cytoskeleton":[247],"rearrangement":[248],"Mass-spectrometry":[251],"identify":[254],"substrates":[257],"currently":[262],"ongoing.":[263,436],"Classical":[264],"pan-HDACi,":[265],"such":[266],"SAHA":[268],"(vorinostat),":[269],"bind":[270],"substantially":[274],"diminished":[275],"activity":[276],"(IC50":[277,314],"=":[278,315],"2":[279],"\u03bcM),":[280],"reflecting":[281],"unique":[283],"binding":[284],"site":[285],"this":[287],"isoform.":[288],"To":[289],"discover":[290],"validate":[292],"new":[293],"small":[294],"molecules":[295],"subtype":[298],"selectivity,":[299],"explored":[302],"efficacy":[304],"OJI-1,":[306],"selective":[309],"potent":[311],"0.8":[316],"nM)":[317],"modest":[319],"HDAC6":[322],"(1200":[323],"nM).":[324],"Treatment":[325],"OJI-1":[327,417],"selectively":[328],"impact":[329],"viability":[331,455],"lines":[339],"(n=20)":[340],"time":[343,380],"dose":[345,382],"dependent":[346,383],"manner,":[347],"while":[348],"sparing":[349],"healthy":[350],"donors":[351],"PBMC":[352],"resting":[355],"activated":[357],"state":[358],"(n=3).":[359],"The":[360],"significantly":[361],"higher":[362],"IC50":[363],"PBMCs":[366],"suggests":[367],"favorable":[369],"index.":[371],"Western":[372],"blotting":[373],"target":[376],"selectivity":[377],"H3":[386],"H4":[388],"acetylation":[389],"treated":[393],"OJI-1.":[395],"specifically":[401],"inhibited":[402],"but":[404],"not":[405],"non-homologous":[406],"end":[407],"joining.":[408],"These":[409],"data":[410,428],"suggest":[411],"that":[412],"targeting":[413],"using":[416],"could":[418],"be":[419,458],"treatment":[421],"approach":[422],"studies":[430],"vivo":[433],"evaluation":[434],"In":[437],"conclusion,":[438],"our":[439],"results":[440],"provide":[441],"insight":[442],"into":[443],"stability":[450],"growth":[453],"which":[456],"can":[457],"exploited":[459],"future":[461],"for":[462],"application":[464],"alone":[465],"Disclosures":[471],"Munshi:":[472],"Takeda:":[473,485],"Consultancy;":[474,476,478,480,482,484,486,488,490,492,494,496,498],"Janssen:":[475,481],"Amgen:":[477,489],"Abbvie:":[479,493],"Celgene:":[483,499],"Adaptive:":[487,491],"Oncopep:":[495,497],"Consultancy.":[500]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-11-22T00:00:00"}